10x Genomics, Inc. TXG Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$13.47M+60.8% | -$16.25M+66.9% | -$27.47M+23.2% | $34.54M+191% | -$34.36M+42.7% | ||
| $9.96M+24.1% | $10.07M+15.0% | $10.3M+14.9% | $7.82M-12.9% | $8.02M-12.7% | ||
| $22.64M-27.1% | $25.22M-22.5% | $25.26M-24.8% | $27.56M-28.4% | $31.08M-14.0% | ||
| —— | $313.25K— | $313.25K— | $313.25K— | $313.25K— | ||
| -$7.98M+77.4% | $0— | -$6.63M+13.7% | -$2.59M-2,025% | -$35.33M-50.2% | ||
| -$2.7M+66.5% | -$5.58M— | -$7.29M-271% | -$7.03M-235% | -$8.06M-181% | ||
| $4.78M+288% | -$5.42M+59.6% | -$196K-105% | $6.04M+438% | -$2.55M-156% | ||
| -$613K— | $5.36M+43.8% | $10.1M+2.2% | -$7.82M-1,248% | $0+100% | ||
| -$1.95M-135% | $2.99M+14.9% | -$1.38M+7.3% | —— | $5.53M+173% | ||
| -$50K-114% | $75K-42.3% | $281K-15.4% | $680K+946% | $360K+44.6% | ||
| -$193K+66.4% | -$393K— | -$434K-800% | -$351K-640% | -$575K-230% | ||
| $77K-77.8% | $1.39M-54.5% | -$190K-108% | -$805K-122% | $347K-83.6% | ||
| $1.95M+9.0% | —— | —— | —— | $1.79M— | ||
| -$2.85M-8.5% | -$2.72M0.0% | -$2.6M+37.5% | -$2.36M+10.7% | -$2.63M+11.1% | ||
| -$18.13M— | —— | —— | $68.48M— | $0— | ||
| $26.12M-24.0% | $40.78M— | $43.21M+99.7% | $17.71M— | $34.35M+318% | ||
| $1.6M-15.6% | $1.78M-34.6% | $687K-82.3% | $1.58M-45.2% | $1.89M-34.9% | ||
| $24.71M— | $24.58M-49.7% | $49.5M— | $49.36M— | $0— | ||
| $25M— | $25.2M— | $50M— | $50M+290% | $0-100% | ||
| -$1.31M+30.7% | -$1.81M+96.5% | -$8.8M-143% | -$939K-108% | -$1.89M-118% | ||
| $273K-35.3% | $2.24M-50.4% | $617K+296% | $3.52M-23.5% | $422K-74.2% | ||
| $8.69M— | —— | —— | —— | $0— | ||
| -$8.42M-2,095% | $2.24M-50.4% | $617K+296% | $3.52M-23.5% | $422K-74.2% | ||
| -$73K-164% | $43K+116% | $0-100% | $360K+12,100% | $114K+338% | ||
| $16.32M-50.5% | $41.26M+176% | $35M+90.9% | $20.65M-14.1% | $32.99M+1,042% | ||
| -$278K-160% | $456K-41.4% | $617K-78.1% | $856K-20.7% | $462K-51.9% | ||
| $57K— | -$272K— | —— | —— | $0— | ||
| -$6.14M-242% | —— | -$7.05M-40.7% | -$7.22M— | $4.33M+134% | ||
| $77K-77.8% | $1.39M-54.5% | -$190K-108% | -$805K-122% | $347K-83.6% | ||
| -$20.96M-78.4% | $5.36M+43.8% | $10.1M+2.2% | $3.93M+777% | -$11.75M-25.2% | ||
| -$2.85M-8.5% | -$2.72M0.0% | -$2.6M+37.5% | -$2.36M+10.7% | -$2.63M+11.1% | ||
| -$50K-114% | $75K-42.3% | $281K-15.4% | $680K+946% | $360K+44.6% | ||
| -$282K+87.8% | —— | —— | -$125K-105% | -$2.31M-971% | ||
| -$18.13M— | —— | —— | $68.48M— | $0— | ||
| -$1.95M-135% | $2.99M+14.9% | -$1.38M+7.3% | —— | $5.53M+173% | ||
| $0-100% | —— | $700K— | —— | $114K-95.4% | ||
| $1.95M+9.0% | —— | —— | —— | $1.79M— | ||
| —— | $313.25K— | $313.25K— | $313.25K— | $313.25K— | ||
| $25M— | $25.2M— | $50M— | $50M+290% | $0-100% | ||
| $273K-35.3% | $2.24M-50.4% | $617K+296% | $3.52M-23.5% | $422K-74.2% | ||
| $118K-70.4% | $80K-79.8% | —— | —— | $398K-79.0% | ||
| -$2.85M-8.5% | -$2.72M0.0% | -$2.6M+37.5% | -$2.36M+10.7% | -$2.63M+11.1% | ||
| $8.7M— | —— | —— | —— | $0— | ||
| -$278K-160% | $456K-41.4% | $617K-78.1% | $856K-20.7% | $462K-51.9% | ||
| $24.52M-24.4% | $39M+512% | $42.53M+140% | $16.13M— | $32.46M+274% | ||
| $24.52M-24.4% | $39M+512% | $42.53M+140% | $16.13M— | $32.46M+274% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does 10x Genomics, Inc.'s cash flow data come from?
- Every line is extracted from 10x Genomics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.